Featured Publications
Early emergency department experience with 7‐day extended‐release injectable buprenorphine for opioid use disorder
D'Onofrio G, Perrone J, Hawk K, Cowan E, McCormack R, Coupet E, Owens P, Martel S, Huntley K, Walsh S, Lofwall M, Herring A, Investigators T. Early emergency department experience with 7‐day extended‐release injectable buprenorphine for opioid use disorder. Academic Emergency Medicine 2023, 30: 1264-1271. PMID: 37501652, PMCID: PMC10822018, DOI: 10.1111/acem.14782.Peer-Reviewed Original ResearchConceptsOpioid use disorderEmergency departmentUse disordersSevere opioid use disorderOngoing clinical trialsEuropean Medicines AgencyEmergency department experienceInjectable buprenorphineClinician barriersED patientsED settingEmergency cliniciansInsurance statusClinical trialsReferral sitesDrug AdministrationMedicines AgencyBuprenorphine preparationsMedicationsU.S. FoodTreatment innovationsBuprenorphineDepartment's experienceEarly experienceDisorders
2018
A Quality Framework for Emergency Department Treatment of Opioid Use Disorder
Samuels EA, D'Onofrio G, Huntley K, Levin S, Schuur JD, Bart G, Hawk K, Tai B, Campbell CI, Venkatesh AK. A Quality Framework for Emergency Department Treatment of Opioid Use Disorder. Annals Of Emergency Medicine 2018, 73: 237-247. PMID: 30318376, PMCID: PMC6817947, DOI: 10.1016/j.annemergmed.2018.08.439.Peer-Reviewed Original ResearchConceptsOpioid use disorder treatmentEmergency department treatmentOpioid-associated morbidityOpioid use disorderClinical Trials NetworkNational InstituteUse disorder treatmentClinical quality improvementOpioid overdose deathsImplementation science researchersQuality improvement effortsQuality measure developmentEmergency cliniciansSafe prescribingOutpatient treatmentDrug Abuse CenterOpioid epidemicQuality improvement frameworkAmerican CollegeData registryOverdose deathsUse disordersDisorder treatmentTrials NetworkAddiction medicine